These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8878950)

  • 21. Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis.
    Pedersen SS; Espersen F; Høiby N; Shand GH
    J Clin Microbiol; 1989 Apr; 27(4):691-9. PubMed ID: 2498389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa infection and cystic fibrosis.
    Kato K; Takayama T
    Lancet; 2002 Jan; 359(9302):262. PubMed ID: 11812595
    [No Abstract]   [Full Text] [Related]  

  • 23. A simple alfalfa seedling infection model for Pseudomonas aeruginosa strains associated with cystic fibrosis shows AlgT (sigma-22) and RhlR contribute to pathogenesis.
    Silo-Suh L; Suh SJ; Sokol PA; Ohman DE
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15699-704. PubMed ID: 12426404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
    Poschet JF; Boucher JC; Firoved AM; Deretic V
    Methods Enzymol; 2001; 336():65-76. PubMed ID: 11398420
    [No Abstract]   [Full Text] [Related]  

  • 25. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease.
    Cobb LM; Mychaleckyj JC; Wozniak DJ; López-Boado YS
    J Immunol; 2004 Nov; 173(9):5659-70. PubMed ID: 15494517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic and environmental mutagenesis drive diversification and persistence of Pseudomonas aeruginosa in chronic lung infections.
    Rodríguez-Rojas A; Oliver A; Blázquez J
    J Infect Dis; 2012 Jan; 205(1):121-7. PubMed ID: 22080096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa infection in cystic fibrosis: biosynthesis of alginate as a virulence factor.
    Roychoudhury S; Zielinski NA; DeVault JD; Kato J; Shinabarger DL; May TB; Maharaj R; Kimbara K; Misra TK; Chakrabarty AM
    Antibiot Chemother (1971); 1991; 44():63-7. PubMed ID: 1801646
    [No Abstract]   [Full Text] [Related]  

  • 28. [Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites].
    Ciragil P; Söyletir G
    Mikrobiyol Bul; 2004 Oct; 38(4):341-7. PubMed ID: 15700659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucoid conversion by phages of Pseudomonas aeruginosa strains from patients with cystic fibrosis.
    Miller RV; Rubero VJ
    J Clin Microbiol; 1984 May; 19(5):717-9. PubMed ID: 6429192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts.
    Rau MH; Hansen SK; Johansen HK; Thomsen LE; Workman CT; Nielsen KF; Jelsbak L; Høiby N; Yang L; Molin S
    Environ Microbiol; 2010 Jun; 12(6):1643-58. PubMed ID: 20406284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.
    Ramsey DM; Wozniak DJ
    Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial ecology and adaptation in cystic fibrosis airways.
    Yang L; Jelsbak L; Molin S
    Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitrosative stress inhibits production of the virulence factor alginate in mucoid Pseudomonas aeruginosa.
    Wood SR; Firoved AM; Ornatowski W; Mai T; Deretic V; Timmins GS
    Free Radic Res; 2007 Feb; 41(2):208-15. PubMed ID: 17364947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of alginate gene expression in Pseudomonas aeruginosa.
    Zielinski NA; Roychoudhury S; Chakrabarty AM
    Methods Enzymol; 1994; 235():493-502. PubMed ID: 8057921
    [No Abstract]   [Full Text] [Related]  

  • 35. Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus?
    Schurr MJ
    J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 32015142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucoid Pseudomonas and the cystic fibrosis lung.
    Russell NJ
    Biochem Soc Trans; 1989 Jun; 17(3):469-71. PubMed ID: 2502454
    [No Abstract]   [Full Text] [Related]  

  • 37. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.
    Vazquez-Espinosa E; Marcos C; Alonso T; Giron RM; Gomez-Punter RM; Garcia-Castillo E; Zamora E; Cisneros C; Garcia J; Valenzuela C; Ancochea J
    Expert Rev Anti Infect Ther; 2016; 14(1):9-17. PubMed ID: 26559549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of exopolysaccharide production by mucoid Pseudomonas aeruginosa.
    Ohman DE
    Eur J Clin Microbiol; 1986 Feb; 5(1):6-10. PubMed ID: 3009178
    [No Abstract]   [Full Text] [Related]  

  • 40. Mucoid Pseudomonas aeruginosa and cystic fibrosis: the role of mutations in muc loci.
    Govan JR; Martin DW; Deretic VP
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):323-9. PubMed ID: 1478467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.